Although the resulting vision is not the same as when these patients had normal vision, investigators involved in the clinical trial of the Argus II are eager about the approval.
Those in the US suffering from blindness due to retinis pigmentosa (RP) will now be able to regain some vision bionically for the first time ever, thanks to Second Sight's Argus II retinal prosthesis.